Osteoporosis Health Center
Alcohol and Osteoporosis
Alcoholism and Recovery
According to the National Institute of Alcohol Abuse and Alcoholism (NIAAA), nearly 14 million Americans – or 1 in 13 adults – abuse alcohol or are alcoholic. Alcoholism is a disease characterized by a dependency on alcohol. Since alcohol affects almost every organ in the body, chronic heavy drinking is associated with many serious health problems, including pancreatitis, liver disease, heart disease, cancer, and osteoporosis. In fact, the NIAAA estimates that the economic costs of alcohol abuse approach $185 billion per year.
Maintaining sobriety is undoubtedly the most important health goal for an individual recovering from alcoholism. However, attention to other aspects of health, including bone health, can help increase the likelihood of a healthy future, free from the devastating consequences of osteoporosis and fracture.
Facts About Osteoporosis
Osteoporosis is a condition in which bones become less dense and more likely to fracture. Fractures from osteoporosis can result in significant pain and disability. It is a major health threat for an estimated 44 million American men and women.
Risk factors for developing osteoporosis include:
- being thin or having a small frame
- having a family history of the disease
- for women, being postmenopausal, having an early menopause, or not having menstrual periods (amenorrhea)
- using certain medications, such as glucocorticoids
- not getting enough calcium
- not getting enough physical activity
- smoking
- drinking too much alcohol.
Osteoporosis is a silent disease that can often be prevented. However, if undetected, it can progress for many years without symptoms until a fracture occurs. It has been called “a pediatric disease with geriatric consequences,” because building healthy bones in one’s youth is important to help prevent osteoporosis and fractures later in life.
The Alcohol – Osteoporosis Link
Alcohol negatively impacts bone health for several reasons. To begin with, excessive alcohol interferes with the balance of calcium, an essential nutrient for healthy bones. It also increases parathyroid hormone (PTH) levels, which in turn reduce the body’s calcium reserves. Calcium balance is further disrupted by alcohol’s ability to interfere with the production of vitamin D, a vitamin essential for calcium absorption.
In addition, chronic heavy drinking can cause hormone deficiencies in men and women. Men with alcoholism tend to produce less testosterone, a hormone linked to the production of osteoblasts (the cells that stimulate bone formation). In women, chronic alcohol exposure often produces irregular menstrual cycles, a factor that reduces estrogen levels, increasing osteoporosis risk. Also, cortisol levels tend to be elevated in people with alcoholism. Cortisol is known to decrease bone formation and increase bone breakdown.
Due to the effects of alcohol on balance and gait, people with alcoholism tend to fall more frequently than those without the disorder. Heavy alcohol consumption has been linked to an increase in the risk of fracture, including the most serious kind: hip fracture. Vertebral fractures are also more common in those who abuse alcohol.
WebMD Public Information from the U.S. National Institutes of Health
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

